Whilst its great to have a committed path forward on Dukas, and the other tenements, giving away 10% on EP112 for no funding/carry isn't a great result for shareholders.
From memory the CTP share in EP112 went from 30-45% with Santos failing to finalise the follow up drilling last year. Whilst they may see this as an cheap concession to get the ball moving and save its bullets on 100% owned Zenon, it would've been preferred if they took the lead and paid the JV share at 45% ownership - just to make the wait worthwhile. In any case they don't have the expertise for this type of well - lets hope Peak do!
That said - given the increasing interest in Hydrogen, there is the good potential for a re-rating of the stock. Whilst the announcement focuses on helium, similarly there aren't many sources of Hydrogen in high concentration found in Australia, and CTP probably has one of the largest acreage of hydrogen prospects in Australia.
- Forums
- ASX - By Stock
- CTP
- Ann: Farmout To Fund Two New Sub-Salt Exploration Wells
CTP
central petroleum limited
Add to My Watchlist
3.45%
!
5.6¢

Ann: Farmout To Fund Two New Sub-Salt Exploration Wells, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.6¢ |
Change
-0.002(3.45%) |
Mkt cap ! $43.22M |
Open | High | Low | Value | Volume |
5.6¢ | 5.6¢ | 5.6¢ | $6.62K | 118.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 100531 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 278794 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 462981 | 0.054 |
1 | 100000 | 0.053 |
4 | 719200 | 0.052 |
1 | 800000 | 0.051 |
2 | 39000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 278794 | 1 |
0.058 | 33753 | 2 |
0.059 | 482673 | 4 |
0.060 | 150000 | 2 |
0.061 | 137146 | 2 |
Last trade - 10.10am 26/06/2025 (20 minute delay) ? |
Featured News
CTP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online